Probability and predictors of relapse to smoking: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Drug and Alcohol Dependence

Volumn 132, Issue 3, 2013, Pages 479-485

  García Rodríguez, Olaya ^a,b   Secades Villa, Roberto ^a,b   Flórez Salamanca, Ludwing ^b   Okuda, Mayumi ^b   Liu, Shang Min ^b   Blanco, Carlos ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

National Epidemiologic Survey of Alcohol and Related Conditions; NESARC; Probability; Relapse; Smoking; Tobacco

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ALCOHOL USE DISORDER; AMERICAN INDIAN; ARTICLE; ASIAN; BIPOLAR DEPRESSION; CANNABIS ADDICTION; CAUCASIAN; CITIZENSHIP; CONDUCT DISORDER; CONTROLLED STUDY; DYSTHYMIA; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; GENDER; GENERALIZED ANXIETY DISORDER; GOOD GENERAL CONDITION; HISPANIC; HUMAN; LIFE EVENT; LOWEST INCOME GROUP; MAJOR DEPRESSION; MALE; MARRIAGE; OBESITY; PANIC; PERSONALITY DISORDER; PHOBIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; RURAL AREA; SMOKING; SMOKING CESSATION; SOCIAL PHOBIA; TOBACCO DEPENDENCE; URBAN AREA;

NICOTIANA TABACUM;

NATIONAL EPIDEMIOLOGIC SURVEY OF ALCOHOL AND RELATED CONDITIONS; NESARC; PROBABILITY; RELAPSE; SMOKING; TOBACCO;

ADOLESCENT; ADULT; ALCOHOL DRINKING; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SMOKING; UNITED STATES; YOUNG ADULT;

EID: 84883557010     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.03.008     Document Type: Article

References (68)

1. Allen S.S., Bade T., Hatsukami D., Center B. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine Tob. Res. 2008, 10:35-45.
2. Bancej C., O'Loughlin J., Platt R.W., Paradis G., Gervais A. Smoking cessation attempts among adolescent smokers: a systematic review of prevalence studies. Tob. Control 2007, 16:e8.
3. Barbeau E.M., Krieger N., Soobader M.J. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am. J. Public Health 2004, 94:269-278.
4. Brandon T.H., Tiffany S.T., Obremski K.M., Baker T.B. Postcessation cigarette use: the process of relapse. Addict. Behav. 1990, 15:105-114.
5. Canino G., Bravo M., Ramirez R., Febo V.E., Rubio-Stipec M., Fernandez R.L., Hasin D. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J. Stud. Alcohol 1999, 60:790-799.
6. Centers for Disease Control and Prevention Cigarette Smoking Among Adults and Trends in Smoking Cessation - United States, 2008. Morb. Mortal. Wkly. Rep. 2009, 58:1227-1232.
7. Centers for Disease Control and Prevention, 2009b. NHIS - adult tobacco use information. Glossary. (accessed 04.03.13.). http://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm.
8. Centers for Disease Control and Prevention Vital signs: current cigarette smoking among adults aged ≥18 years - United States, 2009. Morb. Mortal. Wkly. Rep. 2010, 59:1135-1140.
9. Centers for Disease Control and Prevention Ten great public health achievements - United States, 2001-2010. J. Am. Med. Assoc. 2011, 306:36-38.
10. Covey L.S., Glassman A.H., Stetner F. Major depression following smoking cessation. Am. J. Psychiatry 1997, 154:263-265.
11. Chiamulera C., Borgo C., Falchetto S., Valerio E., Tessari M. Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology (Berl) 1996, 127:102-107.
12. Chornock W.M., Stitzer M.L., Gross J., Leischow S. Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology (Berl) 1992, 108:495-500.
13. Dawson D.A., Grant B.F., Stinson F.S., Chou P.S. Maturing out of alcohol dependence: the impact of transitional life events. J. Stud. Alcohol 2006, 67:195-203.
14. Degenhardt L., Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tob. Res. 2001, 3:225-234.
15. Derby C.A., Lasater T.M., Vass K., Gonzalez S., Carleton R.A. Characteristics of smokers who attempt to quit and of those who recently succeeded. Am. J. Prev. Med. 1994, 10:327-334.
16. Fernandez E., Schiaffino A., Borrell C., Benach J., Ariza C., Ramon J.M., Twose J., Nebot M., Kunst A. Social class, education, and smoking cessation: long-term follow-up of patients treated at a smoking cessation unit. Nicotine Tob. Res. 2006, 8:29-36.
17. Fiore M.C., Jaén C.R., Baker T.B., Bailey W.C., Bennett G., Benowitz N.L., Christiansen B.A. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am. J. Prev. Med. 2008, 35:158-176.
18. George T.P., Vessicchio J.C., Termine A., Bregartner T.A., Feingold A., Rounsaville B.J., Kosten T.R. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol. Psychiatry 2002, 52:53-61.
19. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., Johnson J. Smoking, smoking cessation, and major depression. J. Am. Med. Assoc. 1990, 264:1546-1549.
20. Glassman A.H., Stetner F., Walsh B.T., Raizman P.S., Fleiss J.L., Cooper T.B., Covey L.S. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. J. Am. Med. Assoc. 1988, 259:2863-2866.
21. Grant B.F., Dawson D.A., Hasin D. The Alcohol Use Disorders and Associated Disabilities Interview Schedule - Version DSM-IV, (AUDADIS-IV) 2001, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
22. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71:7-16.
23. Grant B.F., Moore T., Shepard J., Kaplan K. Source and Accuracy Statement: Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 2003, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
24. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., Saha T.D., Smith S.M., Pulay A.J., Pickering R.P., Ruan W.J., Compton W.M. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry 2009, 14:1051-1066.
25. Grant B.F., Hasin D.S., Blanco C., Stinson F.S., Chou S.P., Goldstein R.B., Dawson D.A., Smith S., Saha T.D., Huang B. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2005, 66:1351-1361.
26. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., June Ruan W., Goldstein R.B., Smith S.M., Saha T.D., Huang B. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 2005, 35:1747-1759.
27. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Ruan W.J., Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2005, 66:1205-1215.
28. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., Pickering R.P. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 2004, 65:948-958.
29. Grant B.F., Kaplan K. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 2005, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
30. Harris K.J., Okuyemi K.S., Catley D., Mayo M.S., Ge B., Ahluwalia J.S. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev. Med. 2004, 38:498-502.
31. Hasin D.S., Carpenter K.M., McCloud S., Smith M., Grant B.F. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997, 44:133-141.
32. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatry 2005, 62:1097-1106.
33. Herd N., Borland R., Hyland A. Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 2009, 104:2088-2099.
34. Hitsman B., Borrelli B., McChargue D.E., Spring B., Niaura R. History of depression and smoking cessation outcome: a meta-analysis. J. Consult. Clin. Psychol. 2003, 71:657-663.
35. Holmes T.H., Rahe R.H. The Social Readjustment Rating Scale. J. Psychosom. Res. 1967, 11:213-218.
36. Hughes J.R., Keely J., Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99:29-38.
37. Hughes J.R., Peters E.N., Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict. Behav. 2008, 33:1516-1520.
38. Hurt R.D., Wolter T.D., Rigotti N., Hays J.T., Niaura R., Durcan M.J., Gonzales D., Sachs D.P., Johnston J.A., Offord K.P. Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome. Addict. Behav. 2002, 27:493-507.
39. Kirchner T.R., Shiffman S., Wileyto E.P. Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J. Abnorm. Psychol. 2012, 121:187-197.
40. Koob G.F. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 2006, 101(Suppl. 1):23-30.
41. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
42. Le Strat Y., Rehm J., Le Foll B. How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob. Control 2011, 20:338-343.
43. Ledgerwood D.M. Contingency management for smoking cessation: where do we go from here?. Curr. Drug Abuse Rev. 2008, 1:340-349.
44. Marlatt G.A., Gordon J.R. Relapse Prevention. Maintenance Strategies in the Treatment of Addictive Behaviors 1985, The Guilford Press, New York.
45. Niaura R., Britt D.M., Borrelli B., Shadel W.G., Abrams D.B., Goldstein M.G. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob. Res. 1999, 1:251-257.
46. Niaura R., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. J. Abnorm. Psychol. 1988, 97:133-152.
47. Ockene J.K., Emmons K.M., Mermelstein R.J., Perkins K.A., Bonollo D.S., Voorhees C.C., Hollis J.F. Relapse and maintenance issues for smoking cessation. Health Psychol. 2000, 19:17-31.
48. Oksuz E., Mutlu E.T., Malhan S. Characteristics of daily and occasional smoking among youths. Public Health 2007, 121:349-356.
49. Osler M., Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob. Control 1998, 7:262-267.
50. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., Baker T.B. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J. Abnorm. Psychol. 2003, 112:14-27.
51. Piper M.E., Cook J.W., Schlam T.R., Jorenby D.E., Baker T.B. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction 2011, 106:418-427.
52. Piper M.E., Loh W.Y., Smith S.S., Japuntich S.J., Baker T.B. Using decision tree analysis to identify risk factors for relapse to smoking. Subst. Use Misuse 2011, 46:492-510.
53. Powell J., Dawkins L., West R., Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) 2010, 212:537-549.
54. Ruan W.J., Goldstein R.B., Chou S.P., Smith S.M., Saha T.D., Pickering R.P., Dawson D.A., Huang B., Stinson F.S., Grant B.F. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008, 92:27-36.
55. Schmitz J.M., Rosenfarb I.S., Payne T.J. Cognitive and affective responses to successful coping during smoking cessation. J. Subst. Abuse 1993, 5:61-72.
56. Secades-Villa R., Olfson M., Okuda M., Velasquez N., Pérez-Fuentes G., Liu S., Blanco C. Trends in the prevalence of tobacco use in the United States. Psychiatr. Serv. 2013, 10.1176/appi.ps.002852012.
57. Shadel W.G., Martino S.C., Setodji C., Cervone D., Witkiewitz K., Beckjord E.B., Scharf D., Shih R. Lapse-induced surges in craving influence relapse in adult smokers: an experimental investigation. Health Psychol. 2011, 30:588-596.
58. Shaham Y., Adamson L.K., Grocki S., Corrigall W.A. Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology (Berl) 1997, 130:396-403.
59. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 2003, 168:3-20.
60. Shiffman S., Hickcox M., Paty J.A., Gnys M., Kassel J.D., Richards T.J. Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J. Consult. Clin. Psychol. 1996, 64:993-1002.
61. Shiffman S., Balabanis M.H., Paty J.A., Engberg J., Gwaltney C.J., Liu K.S., Gnys M., Hickcox M., Paton S.M. Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol. 2000, 19:315-323.
62. Shiffman S., Waters A.J. Negative affect and smoking lapses: a prospective analysis. J. Consult. Clin. Psychol. 2004, 72:192-201.
63. Stinson F.S., Dawson D.A., Patricia Chou S., Smith S., Goldstein R.B., June Ruan W., Grant B.F. The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 2007, 37:1047-1059.
64. Swan G.E., Jack L.M., Ward M.M. Subgroups of smokers with different success rates after use of transdermal nicotine. Addiction 1997, 92:207-217.
65. US Department of Health and Human Services Health Benefits of Smoking Cessation: A Report of the Surgeon Generala 1990, Government Printing Office, Washington.
66. Witkiewitz K., Marlatt G.A. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am. Psychol. 2004, 59:224-235.
67. World Health Organization WHO Report on the Global Tobacco Epidemic, 2009, Implementing Smoke-Free Environments 2009, WHO, Geneva.
68. Zhou X., Nonnemaker J., Sherrill B., Gilsenan A.W., Coste F., West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict. Behav. 2009, 34:365-373.